About Magellan BioScience Group
Magellan BioScience Group is a company based in Tampa (United States) founded in 1997 was acquired by Meridian Bioscience in March 2016. Magellan BioScience Group has raised $25 thousand across 2 funding rounds from investors including Meridian Bioscience, NIH and Florida High Tech Corridor. Magellan BioScience Group has completed 1 acquisition, including TREK Diagnostic Systems. Magellan BioScience Group offers products and services including Microbial Strains Library and Pure Peptide Library. Magellan BioScience Group operates in a competitive market with competitors including AnalytiCon Discovery, C2 Pharma, Celtarys, BJ Biochem and Metagreen, among others.
- Headquarter Tampa, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Magellan Bioscience Group Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25 K (USD)
in 2 rounds
-
Latest Funding Round
$25 K (USD), Unspecified
Sep 17, 2012
-
Investors
Meridian Bioscience
& 2 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Meridian Bioscience
(Mar 24, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Magellan BioScience Group
Magellan BioScience Group offers a comprehensive portfolio of products and services, including Microbial Strains Library and Pure Peptide Library.
Collection of over 10,000 microbial strains for drug discovery studies.
Over 2400 pure peptides for high-throughput screening assays.
Funding Insights of Magellan BioScience Group
Magellan BioScience Group has successfully raised a total of $25K across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $25 thousand completed in September 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Magellan BioScience Group
Magellan BioScience Group has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Meridian Bioscience, NIH and Florida High Tech Corridor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
The Florida High Tech Corridor is focused on regional high-tech development.
|
Locked | Locked | Locked | |
|
Molecular diagnostic device and kits
|
Locked | Locked | Locked |
Investor details for Magellan BioScience Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Magellan BioScience Group
Magellan BioScience Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TREK Diagnostic Systems.
Investment portfolio details for Magellan BioScience Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Offers microbiology solution
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Magellan BioScience Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Magellan BioScience Group
Detailed financials for Magellan BioScience Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Magellan Bioscience Group Comparisons
Peer comparison for Magellan BioScience Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Magellan BioScience Group
Magellan BioScience Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnalytiCon Discovery, C2 Pharma, Celtarys, BJ Biochem and Metagreen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Natural products chemistry is specialized in by AnalytiCon Discovery.
|
|
| Locked | Locked | Locked |
Manufactures and distributes active pharmaceutical ingredients and compounds worldwide.
|
|
| Locked | Locked | Locked |
Company that develops and commercializes novel fluorescent probes and ligands for fluorescence-based methods in drug discovery
|
|
| Locked | Locked | Locked |
Research and development services for sugar derivatives are provided.
|
|
| Locked | Locked | Locked |
Develops technologies to harness compounds from natural production.
|
Detailed competitors of Magellan BioScience Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Magellan Bioscience Group
Complete news archive for Magellan BioScience Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Magellan BioScience Group
Magellan BioScience Group was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Magellan BioScience Group is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Magellan BioScience Group is a funded company, having raised a total of $25K across 2 funding rounds to date.
Founded in 1997 and based in Tampa, United States, Magellan BioScience Group operates in the biotechnology sector, focusing on microbial natural products. Research libraries with diverse compounds are offered for applications in pharmaceuticals, agrochemicals, specialty chemicals, and animal health care. Services such as microbial biotransformation, synthetic modifications, and structure elucidation are provided, along with separation and spectroscopic analysis. Partnerships have been established with organizations including BioFlorida, AndroBioSys, and Kemin Pharmaceuticals.
Magellan BioScience Group's top competitors include AnalytiCon Discovery, BJ Biochem and Bicoll.
Magellan BioScience Group offers Microbial Strains Library and Pure Peptide Library.
Magellan BioScience Group has made 1 acquisition, including TREK Diagnostic Systems.
Magellan BioScience Group has 3 investors. Key investors include Meridian Bioscience, NIH, and Florida High Tech Corridor.